Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fosfomycin
2. Fosfomycin Trometamol Salt
3. Fosfomycin Tromethamine
4. Phosphomycin
5. Phosphonomycin
6. Tromethamine, Fosfomycin
1. 78964-85-9 (tromethamine)
2. [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2r,3s)-3-methyloxiran-2-yl]phosphinate
3. Tromethamine-fosfomycin
4. Fosfotricin
5. Monurol Sachet
6. Fosfomycin Compd. With Trometamol
7. Einecs 279-018-8
8. Fosfomycin Tromethaminel
9. Unii-7fxw6u30gy
10. Akos015896108
11. Ac-4209
12. Ks-1266
13. (2r-cis)-(3-methyloxiranyl)phosphonic Acid, Compound With 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1)
Molecular Weight | 259.19 g/mol |
---|---|
Molecular Formula | C7H18NO7P |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 259.08208891 g/mol |
Monoisotopic Mass | 259.08208891 g/mol |
Topological Polar Surface Area | 161 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 190 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11582
Submission : 1995-07-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-06-20
Pay. Date : 2016-12-22
DMF Number : 31195
Submission : 2017-02-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10891
Submission : 1994-04-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-11-21
Pay. Date : 2024-10-18
DMF Number : 40335
Submission : 2024-09-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-04
Pay. Date : 2017-09-27
DMF Number : 31656
Submission : 2017-04-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-05
Pay. Date : 2018-12-06
DMF Number : 33294
Submission : 2018-11-02
Status : Active
Type : II
Certificate Number : R0-CEP 2022-327 - Rev 00
Status : Valid
Issue Date : 2023-05-17
Type : Chemical
Substance Number : 1425
Certificate Number : CEP 2015-289 - Rev 01
Status : Valid
Issue Date : 2024-10-30
Type : Chemical
Substance Number : 1425
Certificate Number : CEP 2017-166 - Rev 03
Status : Valid
Issue Date : 2024-08-02
Type : Chemical
Substance Number : 1425
Certificate Number : CEP 2023-068 - Rev 01
Status : Valid
Issue Date : 2024-03-04
Type : Chemical
Substance Number : 1425
Certificate Number : CEP 2012-265 - Rev 05
Status : Valid
Issue Date : 2024-02-27
Type : Chemical
Substance Number : 1425
Certificate Number : CEP 2020-370 - Rev 03
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 1425
[Japanese Pharmacopoeia] Fosfomycin Calcium
Registration Number : 218MF10649
Registrant's Address : Paseo del Deleite, s/n 28300-Aranjuez, Madrid Spain
Initial Date of Registration : 2006-07-20
Latest Date of Registration : 2007-08-01
Date of Issue : 2021-06-14
Valid Till : 2024-06-13
Written Confirmation Number : WC-0277A2
Address of the Firm : Unit -2, Block No.588, Savli Karachia Road, At & Post- Gothada, Dist Vadodara, G...
Date of Issue : 2021-06-14
Valid Till : 2024-06-13
Written Confirmation Number : WC-0277
Address of the Firm : Unit -2, Block No.588, Savli Karachia Road, At & Post- Gothada, Dist Vadodara, G...
Registrant Name : (주)에스지바이오켐
Registration Date : 2024-05-29
Registration Number : 20240529-211-J-1651
Manufacturer Name : Bajaj Healthcare Limited (Un...
Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara -...
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2024-09-05
Registration Number : 20240529-211-J-1651(1)
Manufacturer Name : Bajaj Healthcare Limited (Un...
Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara -...
Registrant Name : (주)에스지바이오켐
Registration Date : 2025-02-25
Registration Number : 20250225-211-J-1692
Manufacturer Name : Guilin Hwasun Pharmaceutical...
Manufacturer Address : No. 89, 1st street Lingbei Road, LingChuan, Guilin, Guangxi, China
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
NDC Package Code : 40074-0005
Start Marketing Date : 2018-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12836-0318
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52133-0018
Start Marketing Date : 1996-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0066
Start Marketing Date : 1996-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50379-0029
Start Marketing Date : 2024-09-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-1080
Start Marketing Date : 1996-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. It was founded by emerging entrepreneurs and a team of young yet ex...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 40 years of experience in Formulation development, manufacturing and commercialization. It offers a w...
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
About the Company : Bioquim is a European company specializing in bulk oral & sterile APIs for the pharmaceutical industry. With over 40 years of experience, we offer high-quality corticosteroids, pep...
About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...
About the Company : Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and...
About the Company : Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Meitheal has acquired the North American rights to CONTEPO (fosfomycin) from Nabriva. CONTEPO is a novel, intravenous, broad-spectrum antibiotic used for the treatment of urinary tract infections.
Lead Product(s): Fosfomycin Trometamol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Contepo
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Meitheal Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 18, 2024
Lead Product(s) : Fosfomycin Trometamol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Meitheal Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Acquisition
Meitheal Pharmaceuticals Expands Portfolio with Acquisition of CONTEPO™ from Nabriva
Details : Meitheal has acquired the North American rights to CONTEPO (fosfomycin) from Nabriva. CONTEPO is a novel, intravenous, broad-spectrum antibiotic used for the treatment of urinary tract infections.
Product Name : Contepo
Product Type : Small molecule
Upfront Cash : Undisclosed
July 18, 2024
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Fosfomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosfomycin manufacturer or Fosfomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosfomycin manufacturer or Fosfomycin supplier.
PharmaCompass also assists you with knowing the Fosfomycin API Price utilized in the formulation of products. Fosfomycin API Price is not always fixed or binding as the Fosfomycin Price is obtained through a variety of data sources. The Fosfomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fosfomycin Tromethamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosfomycin Tromethamine, including repackagers and relabelers. The FDA regulates Fosfomycin Tromethamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosfomycin Tromethamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosfomycin Tromethamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosfomycin Tromethamine supplier is an individual or a company that provides Fosfomycin Tromethamine active pharmaceutical ingredient (API) or Fosfomycin Tromethamine finished formulations upon request. The Fosfomycin Tromethamine suppliers may include Fosfomycin Tromethamine API manufacturers, exporters, distributors and traders.
click here to find a list of Fosfomycin Tromethamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fosfomycin Tromethamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosfomycin Tromethamine active pharmaceutical ingredient (API) in detail. Different forms of Fosfomycin Tromethamine DMFs exist exist since differing nations have different regulations, such as Fosfomycin Tromethamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fosfomycin Tromethamine DMF submitted to regulatory agencies in the US is known as a USDMF. Fosfomycin Tromethamine USDMF includes data on Fosfomycin Tromethamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosfomycin Tromethamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fosfomycin Tromethamine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fosfomycin Tromethamine Drug Master File in Japan (Fosfomycin Tromethamine JDMF) empowers Fosfomycin Tromethamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fosfomycin Tromethamine JDMF during the approval evaluation for pharmaceutical products. At the time of Fosfomycin Tromethamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fosfomycin Tromethamine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fosfomycin Tromethamine Drug Master File in Korea (Fosfomycin Tromethamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fosfomycin Tromethamine. The MFDS reviews the Fosfomycin Tromethamine KDMF as part of the drug registration process and uses the information provided in the Fosfomycin Tromethamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fosfomycin Tromethamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fosfomycin Tromethamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fosfomycin Tromethamine suppliers with KDMF on PharmaCompass.
A Fosfomycin Tromethamine CEP of the European Pharmacopoeia monograph is often referred to as a Fosfomycin Tromethamine Certificate of Suitability (COS). The purpose of a Fosfomycin Tromethamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fosfomycin Tromethamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fosfomycin Tromethamine to their clients by showing that a Fosfomycin Tromethamine CEP has been issued for it. The manufacturer submits a Fosfomycin Tromethamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fosfomycin Tromethamine CEP holder for the record. Additionally, the data presented in the Fosfomycin Tromethamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fosfomycin Tromethamine DMF.
A Fosfomycin Tromethamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fosfomycin Tromethamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fosfomycin Tromethamine suppliers with CEP (COS) on PharmaCompass.
A Fosfomycin Tromethamine written confirmation (Fosfomycin Tromethamine WC) is an official document issued by a regulatory agency to a Fosfomycin Tromethamine manufacturer, verifying that the manufacturing facility of a Fosfomycin Tromethamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fosfomycin Tromethamine APIs or Fosfomycin Tromethamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Fosfomycin Tromethamine WC (written confirmation) as part of the regulatory process.
click here to find a list of Fosfomycin Tromethamine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosfomycin Tromethamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosfomycin Tromethamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosfomycin Tromethamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosfomycin Tromethamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosfomycin Tromethamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosfomycin Tromethamine suppliers with NDC on PharmaCompass.
Fosfomycin Tromethamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosfomycin Tromethamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosfomycin Tromethamine GMP manufacturer or Fosfomycin Tromethamine GMP API supplier for your needs.
A Fosfomycin Tromethamine CoA (Certificate of Analysis) is a formal document that attests to Fosfomycin Tromethamine's compliance with Fosfomycin Tromethamine specifications and serves as a tool for batch-level quality control.
Fosfomycin Tromethamine CoA mostly includes findings from lab analyses of a specific batch. For each Fosfomycin Tromethamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosfomycin Tromethamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosfomycin Tromethamine EP), Fosfomycin Tromethamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosfomycin Tromethamine USP).